Navigation Links
Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results
Date:11/10/2008

revenue 3,209 3,111 11,662 12,081

Gross margin 9,811 10,754 35,470 34,438

Operating expenses:

Sales and marketing 5,915 6,016 20,330 19,205

Research and development 2,150 2,282 7,054 6,980

General and administrative 2,575 2,695 10,173 8,162

Total operating expenses 10,640 10,993 37,557 34,347

Income (loss) from

operations (829) (239) (2,087) 91

Interest and other income 635 662 1,781 1,846

Loss on investments (863) - (863) -

Income (loss) before

income taxes (1,057) 423 (1,169) 1,937

Provision for income taxes (89) - (175) (147)

Net income (loss) $(1,146) $423 $(1,344) $1,790

Net income (loss) per

share - basic $(0.05) $0.02 $(0.06) $0.08

Net income (loss) per

share - diluted $(0.05) $0.02 $(0.06) $0.07

Weighted average shares

outstanding used in

calculating net income

(loss) per share:

Basic 24,067,548 23,364,409 23,861,079 23,151,949

Diluted 24,067,548 24,882,614 23,861,079 24,825,621

Thermage, Inc NON-GAAP RECONCILIATION OF OPERATING INCOME (LOSS), NET INCOME (LOSS) AND

NET INCOME (LOSS) PER SHARE

(in thousands, except share and per share data)

(unaudited)

Three Months Ended Nine Months Ended

September 30, September 30,


'/>"/>

SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
2. Thermage, Inc. to Present at the Maxim Group Growth Conference
3. Thermage Announces Second Quarter 2008 Financial Results
4. Thermage, Inc. to Present at the Fourth Annual Collins Stewart Growth Conference
5. Thermage and Reliant Technologies to Join Forces
6. Thermage, Inc. to Present at the Bank of America 2008 Healthcare Conference
7. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
8. Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call
9. Thermage, Inc. Announces Initial Shipments of Cellulite Product
10. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
11. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , NEW YORK, Dec. 4 Thousand... 90 offices nationwide today, to participate in a ...tax and advisory firm,s support for literacy with ...ay reflects our firm,s long history of volunteeris...red in the spirit of caring to brighten the holida...
(Date:12/4/2009)... , PEMBROKE, Bermuda, Dec. 4 /PRNewswire...ings, Ltd (NYSE: AWH ) today announced that Scot..., and Jack Sennott, Executive Vice,President and C...g at the 2009,Goldman Sachs U.S. Financial Service...rence Center in New York City on Tuesday, December...
(Date:12/4/2009)... , SCOTTSDALE, Ariz., Dec. 4 H...anaged, non-traded, real estate investment trust, ...eement to acquire a three building medical office ... Texas, and Fort Wayne, Indiana for approximately ...bject to the satisfaction of a number of condition...
(Date:12/4/2009)... , MADISON HEIGHTS, Mich., Dec. 4 /PR... Review Committee of BetterInvesting Magazine to...ts February 2010 "Stock to Study" and C.R. Bard, ...lued Stock" for investors, informational and educa...cause of growth opportunities involving its flagsh...
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire...form would control health care costs, Leapfrog,s p...hrough example -- delivering the best quality care...of efficiency. Thirty-four urban, eight children,s...apfrog Top Hospitals, based on results from The Le...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3
...ertain subset did show raised risk for psychiatric... (HealthDay News) -- Pregnancy alone isn,t associa...ers, a new study says. , It,s been suggested that ...g to background information in the study. , To det...
...mers and advocates join the fight to protect Penns...ate regulations, PHILADELPHIA, July 7 A new orga... for the elderly and the disabled is pushing,for q...ormed this,year to ensure that new licensing rules...
...BURGH, July 7 Both Jerry McGinnis and Pete DeComo...ALung,s board meeting on,July 3, 2008 at which tim...he company also closed on the first $1 million of ...company with annual sales,exceeding $1.3 billion. ...
...he risk seems bigger if certain painkillers are us...ay News) -- The widely prescribed class of antidep...eding in the upper gastrointestinal tract, especia...rotonin reuptake inhibitors family of antidepressa...
... California Healthcare System to Address Key Issue... & Cost, DALLAS, July 7 Zix Corporation (ZixCor...ces for email encryption and,e-prescribing, today ... Director of Information Technology, and Ajay,Chau...
...ng represents a major shift for targeted therapy,...News) -- A molecule that uses a cellular recycling... been identified by Stanford University researcher...er, but it is not well understood how cellular and...
Other Medicine News:Health News:Pregnancy Alone Not A Risk for Mental Health Problems 2Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 2Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 3Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 4Health News:Retired Respironics Chairman Jerry McGinnis and Renal Solutions CEO Pete DeComo Join ALung Technologies Board of Directors; ALung Closes on $1 Million Bridge Financing 2Health News:Popular Antidepressants Linked to GI Bleeding 2Health News:Popular Antidepressants Linked to GI Bleeding 3Health News:Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement 2Health News:Molecule Uses Cellular Recycling to Treat Kidney Cancer 2
(Date:12/4/2009)...c. 4 AstraZeneca (NYSE: ...Administration (FDA) has approved once-daily SEROQ...e Tablets as adjunctive (add-on) treatment to anti...er (MDD). SEROQUEL XR is the only medication in it...pressive disorder as adjunctive therapy and acute ...
(Date:12/3/2009)...3 A genetic variation th...otentially life-threatening blood disorder if expo...ls is one of several medical discoveries scientist...NYSE: DGX ) will present during the 51st America...xposition, December 5-8, 2009, in New Orleans, LA....
(Date:12/3/2009)...Dec. 3 ParagonRx, a Delaware-based...ement and optimal medication use, will host a free...guidance on REMS - Risk Evaluation Mitigation Stra...cycle management. Dr. Gary Slatko, chief medical ...k management programs, will lead the one-hour prog...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BEA Opens the Doors to the World at G20 Summit 58230 1BEA Opens the Doors to the World at G20 Summit 58230 2BEA Opens the Doors to the World at G20 Summit 58230 3New Presentation Highlights Importance of In Hospital Hyperglycemia Management and Appropriate Discharge Planning for Diabetes Patients 58227 1New Presentation Highlights Importance of In Hospital Hyperglycemia Management and Appropriate Discharge Planning for Diabetes Patients 58227 2AMT Appoints New Chief Executive Officer 58224 1AMT Appoints New Chief Executive Officer 58224 2AMT Appoints New Chief Executive Officer 58224 3
...pril 27 MedNet Solutions, a global life sciences ...cal study management systems, today announced the ... speaker, sponsor and exhibitor at the 13th Annual...April 28 through Thursday, April 30 in Orlando, Fl... Mr. David Friend, Director of Key Account Managem...
...l 27 Several new studies presented at the America...ntific Meeting suggest that the use of statins--co...t men with prostate cancer, erectile dysfunction o... research studies highlighting these benefits will... on Monday, April 27 from 9 to 10:30 a.m. during...
Other Medicine Technology:MedNet Solutions to Share Industry Expertise at the 13th Annual EDC & Beyond Conference in Orlando, FL 2New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health 2
..., this is the universal lithotripter for all varie...ment. The system functions primarily as a multipur...g cystoscopy, ureteronoscopy, catheterization, and...omprises the height adjustable urologist' s table....
SONOCUR Basic
...sion! That of the medical data-processing era with... and ease of use. Enjoy the efficiency and therape...ve technology coupled with the precision and simpl... treatment, X-ray and ultrasound images and the as...
...developed by STORZ MEDICAL is the result of many y...y stone lithotripsy and the successful implementat...opaedic apparatus for extracorporeal shock wave th...1 is characterized by its compact size and astonis...
Medicine Products: